Foreword New possibilities are emerging everyday as these novel approaches to healthcare, which also include whole genome sequencing and wearable technology, allow the industry to move into a new era of healthcare. Ripping up the old models of drug development, discovery and commercialisation to take advantage of this new wave of innovation will be hard, but if pharma wants to meet current growth forecasts change is inevitable. Ryan Waters Lisa Urquhart Analyst, Evaluate Ltd Editor, Vantage ® 4 EvaluatePharma World Preview 2019 Copyright © 2019 Evaluate Ltd. All rights reserved.